These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 29634187)

  • 21. Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics.
    Tajdini F; Amini MA; Mokarram AR; Taghizadeh M; Azimi SM
    Pharm Dev Technol; 2014 May; 19(3):333-41. PubMed ID: 23590209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chitosan based nanoparticles as protein carriers for efficient oral antigen delivery.
    Gao P; Xia G; Bao Z; Feng C; Cheng X; Kong M; Liu Y; Chen X
    Int J Biol Macromol; 2016 Oct; 91():716-23. PubMed ID: 27287772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D; Somani VK; Aggarwal S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan Nanoparticles Loaded with Truncated ORF2 Protein as an Oral Vaccine Candidate against Hepatitis E.
    Wei W; Behloul N; Wang W; Baha S; Liu Z; Shi R; Meng J
    Macromol Biosci; 2021 Apr; 21(4):e2000375. PubMed ID: 33624916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
    Jin JW; Tang SQ; Rong MZ; Zhang MQ
    Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
    Slütter B; Plapied L; Fievez V; Sande MA; des Rieux A; Schneider YJ; Van Riet E; Jiskoot W; Préat V
    J Control Release; 2009 Sep; 138(2):113-21. PubMed ID: 19445980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization against HTLV-I with chitosan and tri-methylchitosan nanoparticles loaded with recombinant env23 and env13 antigens of envelope protein gp46.
    Amirnasr M; Fallah Tafti T; Sankian M; Rezaei A; Tafaghodi M
    Microb Pathog; 2016 Aug; 97():38-44. PubMed ID: 27235335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
    Verma V; Tan W; Puth S; Cho KO; Lee SE; Rhee JH
    J Transl Med; 2016 May; 14(1):135. PubMed ID: 27184355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
    Vila A; Sánchez A; Janes K; Behrens I; Kissel T; Vila Jato JL; Alonso MJ
    Eur J Pharm Biopharm; 2004 Jan; 57(1):123-31. PubMed ID: 14729088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic study of the adjuvant effect of chitosan-aluminum nanoparticles.
    Lebre F; Pedroso de Lima MC; Lavelle EC; Borges O
    Int J Pharm; 2018 Dec; 552(1-2):7-15. PubMed ID: 30244149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poria cocos polysaccharide-loaded Alum Pickering emulsion as vaccine adjuvant to enhance immune responses.
    Gu P; Zhu Y; Xu P; Zhao Q; Zhao X; Zhao K; Wang X; Zhang W; Bao Y; Shi W
    Colloids Surf B Biointerfaces; 2024 Dec; 244():114144. PubMed ID: 39116600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of Modified Konjac Glucomannan Nanoparticles and their Application as Vaccine Adjuvants to Promote Ovalbumin-Induced Immune Response in Mice.
    Chen N; Zhu P; Du T; Han K; Wang D; Ye J; Xiao S; Ye X; Wang Y
    Pharm Res; 2018 Mar; 35(5):105. PubMed ID: 29560565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel adjuvant, a mixture of alum and the general opioid antagonist naloxone, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
    Jazani NH; Sohrabpour M; Mazloomi E; Shahabi S
    FEMS Immunol Med Microbiol; 2011 Feb; 61(1):54-62. PubMed ID: 21054579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alum-functionalized graphene oxide nanocomplexes for effective anticancer vaccination.
    Wang X; Cao F; Yan M; Liu Y; Zhu X; Sun H; Ma G
    Acta Biomater; 2019 Jan; 83():390-399. PubMed ID: 30448435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant.
    Mehrabi M; Dounighi NM; Rezayat Sorkhabadi SM; Doroud D; Amani A; Khoobi M; Ajdary S; Pilehvar-Soltanahmadi Y
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):230-240. PubMed ID: 29260901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics, Cryoprotection Evaluation and In Vitro Release of BSA-Loaded Chitosan Nanoparticles.
    Yan Q; Weng J; Wu X; Wang W; Yang Q; Guo F; Wu D; Song Y; Chen F; Yang G
    Mar Drugs; 2020 Jun; 18(6):. PubMed ID: 32549252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-injecting, bioinspired nanocomposite hydrogel that can recruit host immune cells in situ to elicit potent and long-lasting humoral immune responses.
    Korupalli C; Pan WY; Yeh CY; Chen PM; Mi FL; Tsai HW; Chang Y; Wei HJ; Sung HW
    Biomaterials; 2019 Sep; 216():119268. PubMed ID: 31226570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
    Bento D; Staats HF; Gonçalves T; Borges O
    Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chitosan/sulfated locust bean gum nanoparticles: In vitro and in vivo evaluation towards an application in oral immunization.
    Braz L; Grenha A; Ferreira D; Rosa da Costa AM; Gamazo C; Sarmento B
    Int J Biol Macromol; 2017 Mar; 96():786-797. PubMed ID: 28049014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.